Efficacy and safety of recombinant human growth hormone therapy in pediatric intestinal transplant recipients.

Hanh D VoSalaheddin H ElrokhsiAngela K IversonMegan A Keck

Published in: Pediatric transplantation (2022)

Severely growth retarded children after IT could benefit from rhGH treatment. A larger, longitudinal study would be warranted to monitor the long-term effect and safety of rhGH and examine predictors of growth response to rhGH therapy in these pediatric IT recipients.

Keyphrases

recombinant human
growth hormone
young adults
stem cells
bone marrow
chemotherapy induced